Measuring Brain Atrophy in Multiple Sclerosis
Authors:
- Nicola De StefanoNSNicola De Stefano
- Marco BattagliniMBMarco Battaglini
- Stephen M. SmithSSStephen M. Smith
- 6 April 2007
- journal article
- review article
- Published by Wiley in Journal of Neuroimaging
- Vol. 17 (s1) , 10S-15S
Abstract
The last decade has seen the development of methods that use conventional magnetic resonance imaging (MRI) to provide sensitive and reproducible assessments of brain volumes. This has increased the interest in brain atrophy measurement as a reliable indicator of disease progression in many neurological disorders, including multiple sclerosis (MS). After a brief introduction in which we discuss the most commonly used methods for assessing brain atrophy, we will review the most relevant MS studies that have used MRI‐based quantitative measures of brain atrophy, the clinical importance of these results, and the potential for future application of these measures to understand MS pathology and progression. Despite the number of issues that still need to be solved, the measurement of brain atrophy by MRI is sufficiently precise and accurate. It represents one of most promising in vivo measures of neuroaxonal degeneration in MS, and it should be used extensively in the future to assess and monitor pathological evolution and treatment efficacy in this disease.Keywords
This publication has 61 references indexed in Scilit:
- Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 yearsBrain, 2006
- Magnetic resonance imaging measures of brain atrophy in multiple sclerosisJournal of Magnetic Resonance Imaging, 2006
- Imaging brain damage in first‐degree relatives of sporadic and familial multiple sclerosisAnnals of Neurology, 2006
- Semiautomatic brain region extraction: a method of parcellating brain regions from structural magnetic resonance imagesNeuroImage, 2004
- Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4Annals of Neurology, 2004
- Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1aMultiple Sclerosis Journal, 2000
- A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosisMultiple Sclerosis Journal, 2000
- Voxel-Based Morphometry—The MethodsNeuroImage, 2000
- One year follow up study of primary and transitional progressive multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2000